Migraine.site - information about the fixed dose combination of naproxen and sumatriptan SUVEXXTM and the treatment of acute migraine
This section is aimed at healthcare professionals.
About productSumatriptan/naproxen tablets
Prescribing information and Adverse event reporting can be found at the bottom of the page.
Welcome to Migraine.site
Introducing our website, dedicated to providing a wealth of valuable content on the cutting-edge treatment of migraines. Whether you're a general practitioner seeking to enhance your understanding or an expert delving deeper into novel therapies, our platform offers comprehensive insights, research updates, and practical guidance.
From emerging pharmacological interventions to holistic approaches, we cover the spectrum of migraine management. Stay abreast of the latest advancements, connect with fellow professionals, and empower your practice with evidence-based strategies. Welcome to a hub designed to elevate your expertise and improve patient care in the realm of migraine treatment.
We are Orion Pharma
International medical excellence
Orion Pharma is a Finnish pharmaceutical company – a builder of well-being with global operations. We develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients.
Patients' well-being in the core
We collaborate closely with healthcare professionals and leading global research institutions and pharmaceutical companies. Together we take care of patients’ well-being.
Our values & sustainability
We build in all collaboration on mutual trust, appreciation, and diversity. We fight diseases by innovative treatments to improve quality of lives. We know the effects of and requirements for our operations and take responsibility for the entire life cycle of the product.
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Orion Pharma (UK) ltd on 01635 520300.